Melphalan

NEW ORLEANS — In this video perspective, Rahul Banerjee, MD, FACP, discusses potentially practice-changing early research on treatments for newly diagnosed multiple myeloma presented at the ASH Annual Meeting and Exposition.

We have not yet moved away from bone marrow transplant for these patients, and I believe the best outcomes remain with an early transplant.

The FDA granted accelerated approval to melphalan flufenamide in combination with dexamethasone for treatment of certain patients with relapsed or refractory multiple myeloma.

ORLANDO — Autologous hematopoietic stem cell transplantation appeared safe and effective for older patients with multiple myeloma, according to study results presented at ASH Annual Meeting and Exposition.

In this video, Joseph Alvarnas, MD, clinical professor in the department of hematology and hematopoietic cell transplantation at City of Hope, discusses how treatments for multiple myeloma have evolved and where CAR T-cell therapy fits in.